Innoviva, Inc. (INVA)
20.88
+0.22
(+1.06%)
USD |
NASDAQ |
Sep 14, 11:30
Innoviva Max Drawdown (5Y) : 47.01% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 47.01% |
| July 31, 2026 | 47.01% |
| June 30, 2026 | 47.01% |
| May 31, 2026 | 47.01% |
| April 30, 2026 | 47.01% |
| March 31, 2026 | 47.01% |
| February 28, 2026 | 47.01% |
| January 31, 2026 | 47.01% |
| December 31, 2025 | 47.01% |
| November 30, 2025 | 48.70% |
| October 31, 2025 | 49.50% |
| September 30, 2025 | 53.49% |
| August 31, 2025 | 53.49% |
| July 31, 2025 | 53.49% |
| June 30, 2025 | 53.49% |
| May 31, 2025 | 53.49% |
| April 30, 2025 | 53.49% |
| March 31, 2025 | 53.49% |
| February 28, 2025 | 59.57% |
| January 31, 2025 | 59.57% |
| December 31, 2024 | 59.57% |
| November 30, 2024 | 59.57% |
| October 31, 2024 | 59.57% |
| September 30, 2024 | 59.57% |
| August 31, 2024 | 59.57% |
| Date | Value |
|---|---|
| July 31, 2024 | 59.57% |
| June 30, 2024 | 59.57% |
| May 31, 2024 | 59.57% |
| April 30, 2024 | 59.57% |
| March 31, 2024 | 59.57% |
| February 29, 2024 | 59.57% |
| January 31, 2024 | 59.57% |
| December 31, 2023 | 59.57% |
| November 30, 2023 | 59.57% |
| October 31, 2023 | 59.57% |
| September 30, 2023 | 59.57% |
| August 31, 2023 | 59.57% |
| July 31, 2023 | 59.57% |
| June 30, 2023 | 59.57% |
| May 31, 2023 | 59.57% |
| April 30, 2023 | 59.57% |
| March 31, 2023 | 59.57% |
| February 28, 2023 | 59.57% |
| January 31, 2023 | 59.57% |
| December 31, 2022 | 59.57% |
| November 30, 2022 | 60.13% |
| October 31, 2022 | 61.82% |
| September 30, 2022 | 63.26% |
| August 31, 2022 | 63.26% |
| July 31, 2022 | 63.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Zevra Therapeutics, Inc. | 96.86% |
| Collegium Pharmaceutical, Inc. | 51.32% |
| CorMedix, Inc. | 84.47% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -0.3912 |
| Beta (5Y) | 0.3342 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 28.36% |
| Historical Sharpe Ratio (5Y) | 0.0931 |
| Historical Sortino (5Y) | 0.191 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.90% |